Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Addex Therapeutics reports efficacy of ADX-71441 in models of alcohol use disorder

Oct. 14, 2015

Pluristem and FDA agree development pathway for PLX-R18 in ARS

Sep. 21, 2015

Department of Defense awards Cleveland BioLabs contract for development of entolimod

Sep. 7, 2015

Probuphine NDA resubmitted to FDA

Sep. 1, 2015

Regenerative peptide mitigates radiation-induced gastrointestinal damage

Aug. 24, 2015

FDA approves IND for Saniona's NS-2359 in the treatment of cocaine addiction

Aug. 17, 2015

Virginia Commonwealth University patents NO-releasing allosteric Hb modifiers

July 21, 2015

GNI initiates Chinese pilot study of Etuary for radiation-induced pneumonitis

July 8, 2015

NIDA tests AZD-8529 for smoking cessation

July 7, 2015

Invion completes dosing in phase II trial of oral INV-102 in smoking cessation

July 1, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...